Welcome to the International Immunocompromised Host Society


Noteworthy:

    European Conference on Infections in Leukaemia (ECIL) news

 The New Guidelines from ECIL-9 are available for review.  Public comments are welcome and should be addressed to the group leaders denoted on the first slide. 


Basel Meeting news:

Infection and Immunity – Are You Competent? was held September 8 - 11, 2022 in Basel Switzerland.  We thank the co-presidents, Hans H. Hirsch, MD and Mike Recher, MD, plus the respective Society Council members and the local scientific Committee for their dedication to making this congress a real success.

 A Joint meeting of the International Immunocompromised Host Society ICHS (22nd Biennial Symposium) https://www.ichs.org/ and the Swiss Society of Allergy and Immunology SSAI (Annual Conference 2022)  https://ssai.ch/

     8.09.2022 – 11.09.2022 in Basel Switzerland


Please check back soon for updates on the award winners in several categories!

Lifetime Achievement and young investigator awards from the 2022 Biennial Symposium in Basel, Switzerland (here).


**************************

ELECTION NEWS:

Attention all members:

The 2022 ICHS Council election results are available now.  Please check HERE and meet the 2022 - 2024 Council.

****************************************


********************************************************************************************************

Infection and Immunity – Are You Competent?

 A Joint meeting of the International Immunocompromised Host Society ICHS (22nd Biennial Symposium) https://www.ichs.org/ and the Swiss Society of Allergy and Immunology SSAI (Annual Conference 2022)  https://ssai.ch/

     8.09.2022 – 11.09.2022 in Basel Switzerland

Conference Presidents

Hans H. Hirsch, Basel, Switzerland for the ICHS

Mike Recher, Basel, Switzerland, for the SSAI

 

Local Scientific Board

Christoph Berger, Basel

Daniela Finke, Basel

Luca Bernasconi, Aarau

Adrian Egli, Basel

Karin Hartmann, Basel

Ingmar Heijnen, Basel

Hans H. Hirsch, Basel

Nina Khanna, Basel

Karoline Leuzinger, Basel

Nicolas Müller, Zurich

Andri Rauch, Bern

Mike Recher, Basel

Federica Sallusto, Zurich

Roberto Speck, Zurich

Christian van Delden, Geneva

Jean Villard, Geneva

 

International Scientific Board

José-Maria Aguado, Spain

Murat Akova, Turkey

Robin Avery, USA

Roy Chemaly, USA

Tobias Hohl, USA

Thomas Lehrnbecher, Germany

Luis Ostrosky-Zeichner, USA

Monica Slavin, Australia

 

Topics

  • Primary immunodeficiency, acquired immunodeficiency, iatrogenic/therapeutic immunodeficiency, allergy, autoimmune disease
  • Infectious diseases, sepsis, intensive care, immune dysfunction
  • HIV/AIDS, leukemia, hematological and solid cancer chemo-/immunotherapy
  • Transplantation, acute rejection, chronic rejection, graft-versus-host disease
  • Clinical syndromes, diagnostic procedures, imaging studies
  • Antivirals, antibiotics, antifungals, antiparasitic drugs and integrated therapies
  • Vaccination, immune modulation, immunoglobulins, adoptive immune cell therapy
  • Translational virology, mycology, bacteriology, parasitology, immunology

Confirmed Speakers

José-Maria Aguado, (Madrid, Spain)

Murat Akova, (Ankara, Turkey)

Robin Avery, (Baltimore, MD, USA)

Lindsey Baden, (Boston, MA, USA)

Pierre-Yves Bochud, (Lausanne, Switzerland)

Jens Bremerich, (Basel, Switzerland)

Jean-Laurent Casanova, (New York, USA) & (Paris, France)

Thierry Calandra, (Lausanne Switzerland)

Roy Chemaly, (Houston, TX, USA)

Patrizia Comoli, (Pavia, Italy)

Sanjeet Dadhwal, (City of Hope, CA, USA)

Christine Durand, (Baltimore, MD, USA)

Adrian Egli, (Basel, Switzerland)

Stephan Ehl, (Freiburg, Germany)

Mario Fernandez-Ruiz, (Madrid, Spain)

Jay A. Fishman, (Boston, MA, USA)

Dela Golshayan, (Lausanne, Switzerland)

Paolo Grossi, (Varese, Italy)

Natasha Halasa (Nashville, TN, USA)

Marcus Heim (Basel, Switzerland)

Christoph Hess, (Cambridge, UK) & (Basel, Switzerland)

Tobias Hohl, (New York, USA)

Steven Holland, (Bethesda, MD, (NIAID), USA)

Eddie Holmes, (Melbourne, Australia)

Mike Ison, (Chicago, IL, USA)

Nassim Kamar, (Toulouse, France)

Nina Khanna, (Basel, Switzerland)

Camile Kotton, (Boston, MA, USA)

Thomas Lehrnbecher, (Frankfurt, DER)

Per Ljungman, (Stockholm, Sweden)

Alexandre Loupy, (Paris, France)

Jens Lundgren, (Copenhagen, Denmark)

Johann Maertens, (Leiden, Belgium)

Georg Maschmeyer, (Berlin, Germany)

Malgorzata Milkulska, (Genoa, Italy)

Josh Milner, (Bethesda, MD (NIH), USA)

Darius Moradpour, (Lausanne, Switzerland)

Zenia Papanicolaou, (New York, USA)

Steven Pergam, (Seattle, WA, USA)

Francesco R. Simonetti, (Baltimore, MD, USA)

Monica Slavin, (Melbourne, Australia)

Marie von Lilienfeld-Toal, (Jena, Germany)

Rolf Zinkernagel, (Zurich, Switzerland)

 

Formats

Plenary sessions, parallel sessions, meet-the-expert sessions, pro & con debate, case presentation, panel arena, abstract sessions, posters and poster walks, industry symposia industry lunch symposia, industry exhibition, networking opportunities, late-breaker, awards.


Supporting Societies

ESCMID, ESCMID Study group Immunocompromised Hosts (ESGICH), ESCMID Study group for Respiratory Viruses (ESGREV), SSAI, SSID.


Supporting Organizations and Institutions

City of Basel, University Hospital Basel, University of Basel, NIH.

*****************************************************************************************


Hear from our Council!

Several members of our International  Council have recorded messages about the ICHS Society and the 2021 Symposium.  Click here to hear what they have to say!



Upcoming events


Looking for new opportunities? 

ICHS is helping to support our community by advertising employment opportunities. 

Visit our new page




Please visit the MSGERC Mycoses Study Group Education & Research Consortium website MSGERC.ORG to keep up with the latest news!


Be sure to visit the NEW Doctor Fungus Website at msgercdoctorfungus.com/   You'll find a wealth of valuable information!

European Conference on Infections in Leukaemia (ECIL) news

 The New Guidelines from ECIL-9 are available for review.  Public comments are welcome and should be addressed to the group leaders denoted on the first slide. 


© International Immunocompromised Host Society
Powered by Wild Apricot Membership Software